Sign in
4

Changes in Ownership

Lipocine Inc. Filed Acc 0001493152-26-031377

Options or other derivatives

  • Chief Executive Officer acquired 52,781 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Patel Mahesh V. Chief Executive Officer 2026-06-29 Grant or award · Stock Option (Right to Buy) +52,781 $2.49 $131,425 227,214 D
Loading xslF345X06/ownership.xml…